Why India being a $300-billion bioeconomy by 2030 is just the tip of the iceberg

economictimes.indiatimes.com:

economy is expected to grow from $3 trillion to $26 trillion by 2047. Given the scale at which India is expected to grow over the next two decades, biotechnology can be a critical enabler towards the economy’s quest for green and sustainable choices.
But it may not be such an easy terrain to traverse. “India is rapidly expanding.

So it is important to look from tomorrow's perspective — the upcoming decade, the next few decades. You can just visualise what this would mean in terms of the current practices that we are adopting and then fast forward to 2047 – it's a mind-boggling impact. If you try to visualise this, it is not a very bright spot.

It is very gloomy,” Krishna Mohan Puvvada, Regional President-India of global biotechnology company Novozymes, said while speaking at the 18th Sustainability Summit, a flagship event of CII, in the capital on Tuesday.
Biotechnology is known to have a range of applications, the most notable ones being in medicine and agriculture. Considered a sunrise sector within the Indian economy, it includes industries such as bio-IT, bio-services, pharmaceuticals, agriculture and chemicals, among others.
Puvvada said there was a need to think beyond obvious challenges while also aiming high and finding a new audience for mankind’s ecosystems. “This is where a lot of technologies will need to come into play.

Biotech is one such part – it's a very important pathway. Because what it can do is nothing short of magic,” he stated. Explaining how a lot of products are essentially fossil fuel-based, which needs to change, Puvvada said that tackling the issue from a biotech adoption perspective can help save 3 gigatons of CO2.